CRIS — CURIS INC
—
Nasdaq ·
Health Care ·
Biotechnology ·
CIK 1108205 ·
Last close
$0.54
Market Cap
$3.62M
52W High
$28.40
52W Low
$0.33
ADV30
8,400,622
Next earnings
2026-11-12
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Sep 2026 | — | — | — | — | — | — | — |
| Jun 2026 | 0 | 0 | -9,940,000 | -8,581,000 | 18,970,000 | 5,073,000 | 14,275,000 |
| Mar 2026 | 0 | 0 | -11,519,000 | -24,199,000 | 29,686,000 | 15,001,000 | 16,979,000 |
| Dec 2025 | 1,138,000 | 1,138,000 | -7,570,000 | 19,356,000 | 19,966,000 | 5,061,000 | 14,504,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-30,587,000
Investing CF
$2,500,000
Financing CF
$23,022,000
CapEx
—
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-14.22
As of
2026-11-15
Balance + Analyst (yfinance extras)
Retained Earnings
$-1,280,161,000
Inventory
—
Receivables
$0
ST Investments
—
EBIT TTM
$-8,448,000
Pretax Income TTM
$-21,153,000
Interest Exp TTM
—
Analysts
3
Yahoo Snapshot (yfinance, live)
Total Revenue
$4,314,000
EBITDA
$-35,869,000
Free Cash Flow
$-15,766,000
Enterprise Value
$-2,833,894
Total Cash
$5,073,000
Total Debt
$1,044,000
Shares Out
6,679,229
Trailing EPS
$1.32
Book Value
$8.45
ROE
-693.9%
ROA
-93.2%
Div Yield
0.00%
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 9,443,000 | -32,902,000 | -7,582,000 | 19,966,000 | 14,504,000 | 5,462,000 | -27,201,000 |
| Dec 2024 | 10,908,000 | -44,542,000 | -43,389,000 | 41,265,000 | 47,263,000 | -5,998,000 | -39,563,000 |
| Dec 2023 | 10,023,000 | -48,332,000 | -47,413,000 | 77,282,000 | 57,612,000 | 19,670,000 | -38,434,000 |
| Dec 2022 | 10,162,000 | -53,020,000 | -56,672,000 | 108,848,000 | 62,296,000 | 46,552,000 | -54,337,000 |
TTM Snapshot
Revenues TTM
$4,314,000
NetIncome TTM
$-21,153,000
OpCashFlow TTM
—
Assets (Latest)
$18,970,000
Forward EPS
$-5.60
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| CELZ | CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. | $3.62M | $0.48 | — |
| LIMN | Liminatus Pharma, Inc. | $3.77M | $2.81 | — |
| SNTI | Senti Biosciences Holdings, Inc. | $3.02M | $0.10 | — |
| BCAB | BioAtla, Inc. | $3.00M | $1.80 | — |
| SCLX | Scilex Holding Co | $4.52M | $0.64 | — |
News headlines (Yahoo Finance, 1h cache)
Curis (CRIS) Stock Fair Value Falls After Q3 And Private Placement Rework
2026-11-18 17:13 · Yahoo
Curis, Inc. Q3 2026 Earnings Call Summary
2026-11-13 13:30 · Yahoo
Curis (CRIS) Q3 2026 Earnings Call Transcript
2026-11-13 07:13 · Yahoo
Curis: Q3 Earnings Snapshot
2026-11-12 21:07 · Yahoo
Curis Provides Third Quarter 2026 Business Update
2026-11-12 21:01 · Yahoo
Curis to Report Third Quarter 2026 Financial and Operating Results and Host Conference Call and Webcast on November 12, 2026
2026-11-05 21:30 · Yahoo
BC-Most Active Stocks
2026-11-04 15:30 · Yahoo
Curis Shares Surge 70.7% as Reverse Stock Split Vote and Upcoming Clinical Data Attract Investors
2026-11-04 13:42 · Yahoo
Curis, Inc. Announces Pricing of $8.5 Million Private Placement Priced At-the-Market Under Nasdaq Rules with Existing Healthcare Focused Institutional Investors
2026-10-16 12:00 · Yahoo
VISTA Inhibitor Market Insights Report 2026 | Featuring Profiles of Aurigene Discovery Technologies, Curis, Hummingbird Bioscience, Kineta, PharmAbcine
2026-08-26 14:16 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.